BCDA BioCardia, Inc.
Nasdaq · SEC CIK 925741 · EDGAR
- Bought, last 12 months
- $168.2K 21 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 152 since 2021-08-18, latest 2026-09-23 20:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| STERTZER SIMON H | Dir | $103.6K | — |
| Altman Peter | Pres, CEO, Dir | $64.6K | — |
| McClung David | CFO | — | — |
| GILLIS EDWARD M | SVP, Devices | — | — |
Transactions 128
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-22 | 2023-05-18 | BCDA | GILLIS EDWARD M | SVP, Devices | A - Grant | $1.70 | +40.5K | 40.5K | New | +$68.8K |
| D | 2023-05-22 | 2023-05-18 | BCDA | McClung David | CFO | A - Grant | $1.70 | +61.4K | 152.1K | +68% | +$104.4K |
| 2023-04-14 | 2022-01-11 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.87 | +100 | 353.7K | +0.0% | +$187 | |
| A | 2023-04-14 | 2022-05-13 | BCDA | Altman Peter | Pres, CEO, Dir | A - Grant | $1.37 | -3,498 | 348.9K | -1.0% | -$4,792 |
| A | 2023-04-07 | 2022-05-12 | BCDA | Altman Peter | Pres, CEO, Dir | F - Tax | $1.32 | -26.5K | 321.7K | -8% | -$34.9K |
| A | 2023-04-07 | 2022-05-12 | BCDA | McClung David | CFO | A - Grant | $1.32 | -17.3K | 79.8K | -18% | -$22.9K |
| I | 2022-12-20 | 2022-12-16 | BCDA | FROST PHILLIP MD ET AL | 10% | P - Purchase | $1.68 | +595.2K | 2.03M | +42% | +$1000.0K |
| 2022-12-19 | 2022-12-16 | BCDA | Altman Peter | Pres, CEO, Dir | A - Grant | $1.68 | +14.9K | 347.8K | +4% | +$25.0K | |
| I | 2022-12-19 | 2022-12-16 | BCDA | Blank Andrew Scott | Dir | A - Grant | $1.68 | +148.8K | 291.7K | +104% | +$250.0K |
| I | 2022-12-19 | 2022-12-16 | BCDA | STERTZER SIMON H | Dir | A - Grant | $1.68 | +178.6K | 888.1K | +25% | +$300.0K |
| 2022-12-19 | 2022-12-16 | BCDA | McClung David | CFO | A - Grant | $1.68 | +8,928 | 87.4K | +11% | +$15.0K | |
| 2022-12-19 | 2022-12-16 | BCDA | Allen Jim L. | Dir | A - Grant | $1.68 | +148.8K | 830.5K | +22% | +$250.0K | |
| M | 2022-11-14 | 2022-11-10+ | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.87 | +4,500 | 332.9K | +1% | +$8,401 |
| 2022-10-11 | 2022-10-10 | BCDA | McClung David | CFO | P - Purchase | $2.07 | +2,000 | 78.5K | +3% | +$4,140 | |
| M | 2022-09-26 | 2022-09-22+ | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.83 | +4,500 | 328.4K | +1% | +$8,229 |
| 2022-09-22 | 2022-09-21 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.92 | +2,750 | 323.9K | +0.9% | +$5,280 | |
| 2022-06-13 | 2022-06-10 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.46 | +4,500 | 321.2K | +1% | +$6,570 | |
| 2022-05-18 | 2022-05-12 | BCDA | GILLIS EDWARD M | SVP, Devices | F - Tax | $1.32 | -12.4K | 23.9K | -34% | -$16.3K | |
| 2022-05-18 | 2022-05-12 | BCDA | McClung David | CFO | F - Tax | $1.32 | -20.6K | 76.5K | -21% | -$27.2K | |
| 2022-05-18 | 2022-05-12 | BCDA | Altman Peter | Pres, CEO, Dir | F - Tax | $1.32 | -31.4K | 316.7K | -9% | -$41.5K | |
| M | 2022-05-13 | 2022-05-11+ | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.24 | +15.0K | 334.1K | +5% | +$18.6K |
| M | 2022-05-02 | 2022-04-28+ | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.60 | +5,000 | 333.1K | +2% | +$8,004 |
| D | 2022-04-18 | 2022-04-14 | BCDA | Altman Peter | Pres, CEO, Dir | A - Grant | $0.00 | +76.7K | 314.6K | +32% | $0 |
| D | 2022-04-18 | 2022-04-18 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $1.39 | +13.5K | 328.1K | +4% | +$18.8K |
| D | 2022-04-18 | 2022-04-14 | BCDA | McClung David | CFO | A - Grant | $0.00 | +50.3K | 97.2K | +108% | $0 |
| D | 2022-04-18 | 2022-04-14 | BCDA | GILLIS EDWARD M | SVP, Devices | A - Grant | $0.00 | +30.2K | 36.2K | +496% | $0 |
| 2021-11-18 | 2021-11-18 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $2.20 | +5,000 | 237.9K | +2% | +$11.0K | |
| 2021-08-18 | 2021-08-17 | BCDA | Altman Peter | Pres, CEO, Dir | P - Purchase | $2.94 | +3,500 | 232.9K | +2% | +$10.3K |
Purchase Sale Sale after option exercise All abbreviations